DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tasigna (Nilotinib) - News

 
 



News related to Tasigna (Nilotinib) and/or conditions it is approved for

New study may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.23]
Researchers at NYU Langone Medical Center conclude new drug in development may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia.

Many older people have mutations linked to leukemia, lymphoma in their blood cells
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.21]
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University...

Personalized cellular therapy achieves complete remission in 90 percent of acute lymphoblastic leukemia patients studied
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.20]
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an...

CNIO researchers associate 2 oncogenes with the aggressiveness and incidence of leukemia in mice
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.14]
Proteins regulating cell division determine tumour growth. Ongoing clinical trials are currently studying inhibitors for two of these proteins, Cdk4 and Cdk6, targeting several types of cancer...

Positive top-line Phase III results from clinical study with GRASPA(R) in Acute Lymphoblastic Leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.02]
ERYTECH, the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other oncology indications with unmet medical needs, reports positive...

Cancer drug plays dual purpose in regulating expression of genes in leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.29]
Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures.

Improved survival for children with a leukemia subtype associated with poor prognosis
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.26]
St. Jude Children's Research Hospital study shows that adjusting treatment based on early response to chemotherapy boosts survival of young patients with Philadelphia chromosome-like acute...

How the battle for cell production could be decisive in the war on leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.22]
A key step in understanding the nature of the fight for superiority between mutated genes and normal genes could lead to new therapies to combat leukaemia, say researchers from the University of...

Killing leukemia cells by disrupting their metabolism doesn't harm normal cells
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.15]
A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts.

Genomic analysis reveals that a high-risk leukemia subtype becomes more common with age
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.12]
More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat...

Leukemia patients to benefit from novel cancer drug
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.11]
Results of a Phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy.

Hospital Admission Day Tied to Outcomes for Children With Leukemia
Source: MedicineNet Leukemia Specialty [2014.08.26]
Title: Hospital Admission Day Tied to Outcomes for Children With Leukemia
Category: Health News
Created: 8/25/2014 4:35:00 PM
Last Editorial Review: 8/26/2014 12:00:00 AM

FDA Expands Use of Imbruvica for Form of Leukemia
Source: MedicineNet Leukemia Specialty [2014.07.29]
Title: FDA Expands Use of Imbruvica for Form of Leukemia
Category: Health News
Created: 7/28/2014 4:35:00 PM
Last Editorial Review: 7/29/2014 12:00:00 AM

Nonadherence to leukemia maintenance medication in childhood triples relapse risk
Source: Compliance News From Medical News Today [2014.06.04]
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse...

Leukemia
Source: MedicineNet Carpal Tunnel Syndrome Specialty [2014.03.14]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/14/2014 12:00:00 AM

New Drug Combo Might Help Older, Sicker Patients With Leukemia
Source: MedicineNet rituximab Specialty [2014.01.10]
Title: New Drug Combo Might Help Older, Sicker Patients With Leukemia
Category: Health News
Created: 1/9/2014 2:35:00 PM
Last Editorial Review: 1/10/2014 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014